(CAMT) Camtek - Ratings and Ratios
Exchange: NASDAQ •
Country: Israel •
Currency: USD •
Type: Common Stock •
ISIN: IL0010952641
Inspection, Metrology, Semiconductor, Packaging, Wafer
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 57.2% |
| Value at Risk 5%th | 89.6% |
| Relative Tail Risk | -4.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.89 |
| Alpha | 30.51 |
| CAGR/Max DD | 1.10 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.522 |
| Beta | 1.778 |
| Beta Downside | 1.659 |
| Drawdowns 3y | |
|---|---|
| Max DD | 63.16% |
| Mean DD | 20.02% |
| Median DD | 11.09% |
Description: CAMT Camtek November 07, 2025
Camtek Ltd. (NASDAQ:CAMT) designs, manufactures, and sells inspection and metrology systems for the global semiconductor supply chain, serving customers in the United States, China, Korea, Europe, and the Asia-Pacific region.
Its product lineup spans the Eagle family (Eagle-i, Eagle-AP, Golden Eagle, Hawk, Eagle G5) for 2D/3D wafer and panel inspection, and the MicroProf series (AP, DI, FE, FS, PT, MHU, TL, 100-300) that cover wafer-level metrology, hybrid metrology, and surface-sensing applications across advanced packaging, MEMS, sapphire, and LED markets.
Key recent metrics: FY 2023 revenue rose ~12% YoY to $210 million, driven by a 30% increase in sales to advanced-packaging customers; gross margin improved to 48% as higher-value 3D inspection units gained traction; and the company’s backlog grew to roughly 18 months, reflecting strong demand for 2.5-D/3-D packaging solutions. Macro drivers include the industry-wide shift toward heterogeneous integration and the projected 20% CAGR growth in the advanced packaging market through 2030, which underpins Camtek’s addressable market.
For a deeper, data-rich assessment of Camtek’s valuation and risk profile, you may find ValueRay’s analytical toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (47.8m TTM) > 0 and > 6% of Revenue (6% = 29.1m TTM) |
| FCFTA 0.09 (>2.0%) and ΔFCFTA 0.66pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 161.0% (prev 121.5%; Δ 39.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 122.2m > Net Income 47.8m (YES >=105%, WARN >=100%) |
| Net Debt (319.4m) to EBITDA (62.6m) ratio: 5.10 <= 3.0 (WARN <= 3.5) |
| Current Ratio 7.58 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (45.8m) change vs 12m ago -7.45% (target <= -2.0% for YES) |
| Gross Margin 50.36% (prev 47.83%; Δ 2.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 46.83% (prev 47.61%; Δ -0.79pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 743.2 (EBITDA TTM 62.6m / Interest Expense TTM 37.0k) >= 6 (WARN >= 3) |
Altman Z'' 5.84
| (A) 0.63 = (Total Current Assets 899.8m - Total Current Liabilities 118.7m) / Total Assets 1.23b |
| (B) 0.28 = Retained Earnings (Balance) 350.6m / Total Assets 1.23b |
| (C) 0.03 = EBIT TTM 27.5m / Avg Total Assets 1.04b |
| (D) 0.54 = Book Value of Equity 352.3m / Total Liabilities 653.0m |
| Total Rating: 5.84 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 58.57
| 1. Piotroski 5.50pt |
| 2. FCF Yield 2.39% |
| 3. FCF Margin 23.11% |
| 4. Debt/Equity 0.90 |
| 5. Debt/Ebitda 5.10 |
| 6. ROIC - WACC (= -8.64)% |
| 7. RoE 8.17% |
| 8. Rev. Trend 91.86% |
| 9. EPS Trend 94.37% |
What is the price of CAMT shares?
As of December 04, 2025, the stock is trading at USD 110.90 with a total of 1,168,846 shares traded.
Over the past week, the price has changed by +7.31%, over one month by -10.16%, over three months by +41.35% and over the past year by +46.97%.
Over the past week, the price has changed by +7.31%, over one month by -10.16%, over three months by +41.35% and over the past year by +46.97%.
Is CAMT a buy, sell or hold?
Camtek has received a consensus analysts rating of 4.56.
Therefore, it is recommended to buy CAMT.
- Strong Buy: 6
- Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CAMT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 125.6 | 13.3% |
| Analysts Target Price | 125.6 | 13.3% |
| ValueRay Target Price | 163.4 | 47.4% |
CAMT Fundamental Data Overview November 29, 2025
Market Cap USD = 4.82b (4.82b USD * 1.0 USD.USD)
P/E Trailing = 104.2525
P/E Forward = 32.4675
P/S = 9.9311
P/B = 8.2556
P/EG = 2.1655
Beta = 1.571
Revenue TTM = 485.2m USD
EBIT TTM = 27.5m USD
EBITDA TTM = 62.6m USD
Long Term Debt = 519.1m USD (from longTermDebt, last quarter)
Short Term Debt = 2.49m USD (from shortTermDebt, last fiscal year)
Debt = 519.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 319.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.70b USD (4.82b + Debt 519.1m - CCE 639.5m)
Interest Coverage Ratio = 743.2 (Ebit TTM 27.5m / Interest Expense TTM 37.0k)
FCF Yield = 2.39% (FCF TTM 112.1m / Enterprise Value 4.70b)
FCF Margin = 23.11% (FCF TTM 112.1m / Revenue TTM 485.2m)
Net Margin = 9.86% (Net Income TTM 47.8m / Revenue TTM 485.2m)
Gross Margin = 50.36% ((Revenue TTM 485.2m - Cost of Revenue TTM 240.9m) / Revenue TTM)
Gross Margin QoQ = 50.04% (prev 50.77%)
Tobins Q-Ratio = 3.82 (Enterprise Value 4.70b / Total Assets 1.23b)
Interest Expense / Debt = 0.01% (Interest Expense 37.0k / Debt 519.1m)
Taxrate = 14.99% (-9.38m / -62.6m)
NOPAT = 23.4m (EBIT 27.5m * (1 - 14.99%))
Current Ratio = 7.58 (Total Current Assets 899.8m / Total Current Liabilities 118.7m)
Debt / Equity = 0.90 (Debt 519.1m / totalStockholderEquity, last quarter 578.0m)
Debt / EBITDA = 5.10 (Net Debt 319.4m / EBITDA 62.6m)
Debt / FCF = 2.85 (Net Debt 319.4m / FCF TTM 112.1m)
Total Stockholder Equity = 585.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 47.8m / Total Assets 1.23b)
RoE = 8.17% (Net Income TTM 47.8m / Total Stockholder Equity 585.4m)
RoCE = 2.49% (EBIT 27.5m / Capital Employed (Equity 585.4m + L.T.Debt 519.1m))
RoIC = 2.71% (NOPAT 23.4m / Invested Capital 863.8m)
WACC = 11.35% (E(4.82b)/V(5.34b) * Re(12.57%) + D(519.1m)/V(5.34b) * Rd(0.01%) * (1-Tc(0.15)))
Discount Rate = 12.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.51%
[DCF Debug] Terminal Value 68.13% ; FCFE base≈95.7m ; Y1≈118.1m ; Y5≈201.4m
Fair Price DCF = 38.47 (DCF Value 1.76b / Shares Outstanding 45.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 94.37 | EPS CAGR: 18.78% | SUE: 0.77 | # QB: 0
Revenue Correlation: 91.86 | Revenue CAGR: 15.18% | SUE: 0.57 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.68 | Chg30d=-0.140 | Revisions Net=-7 | Analysts=10
EPS next Year (2026-12-31): EPS=3.29 | Chg30d=-0.239 | Revisions Net=-6 | Growth EPS=+2.9% | Growth Revenue=+5.3%
P/E Trailing = 104.2525
P/E Forward = 32.4675
P/S = 9.9311
P/B = 8.2556
P/EG = 2.1655
Beta = 1.571
Revenue TTM = 485.2m USD
EBIT TTM = 27.5m USD
EBITDA TTM = 62.6m USD
Long Term Debt = 519.1m USD (from longTermDebt, last quarter)
Short Term Debt = 2.49m USD (from shortTermDebt, last fiscal year)
Debt = 519.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 319.4m USD (from netDebt column, last quarter)
Enterprise Value = 4.70b USD (4.82b + Debt 519.1m - CCE 639.5m)
Interest Coverage Ratio = 743.2 (Ebit TTM 27.5m / Interest Expense TTM 37.0k)
FCF Yield = 2.39% (FCF TTM 112.1m / Enterprise Value 4.70b)
FCF Margin = 23.11% (FCF TTM 112.1m / Revenue TTM 485.2m)
Net Margin = 9.86% (Net Income TTM 47.8m / Revenue TTM 485.2m)
Gross Margin = 50.36% ((Revenue TTM 485.2m - Cost of Revenue TTM 240.9m) / Revenue TTM)
Gross Margin QoQ = 50.04% (prev 50.77%)
Tobins Q-Ratio = 3.82 (Enterprise Value 4.70b / Total Assets 1.23b)
Interest Expense / Debt = 0.01% (Interest Expense 37.0k / Debt 519.1m)
Taxrate = 14.99% (-9.38m / -62.6m)
NOPAT = 23.4m (EBIT 27.5m * (1 - 14.99%))
Current Ratio = 7.58 (Total Current Assets 899.8m / Total Current Liabilities 118.7m)
Debt / Equity = 0.90 (Debt 519.1m / totalStockholderEquity, last quarter 578.0m)
Debt / EBITDA = 5.10 (Net Debt 319.4m / EBITDA 62.6m)
Debt / FCF = 2.85 (Net Debt 319.4m / FCF TTM 112.1m)
Total Stockholder Equity = 585.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.89% (Net Income 47.8m / Total Assets 1.23b)
RoE = 8.17% (Net Income TTM 47.8m / Total Stockholder Equity 585.4m)
RoCE = 2.49% (EBIT 27.5m / Capital Employed (Equity 585.4m + L.T.Debt 519.1m))
RoIC = 2.71% (NOPAT 23.4m / Invested Capital 863.8m)
WACC = 11.35% (E(4.82b)/V(5.34b) * Re(12.57%) + D(519.1m)/V(5.34b) * Rd(0.01%) * (1-Tc(0.15)))
Discount Rate = 12.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.51%
[DCF Debug] Terminal Value 68.13% ; FCFE base≈95.7m ; Y1≈118.1m ; Y5≈201.4m
Fair Price DCF = 38.47 (DCF Value 1.76b / Shares Outstanding 45.8m; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: 94.37 | EPS CAGR: 18.78% | SUE: 0.77 | # QB: 0
Revenue Correlation: 91.86 | Revenue CAGR: 15.18% | SUE: 0.57 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.68 | Chg30d=-0.140 | Revisions Net=-7 | Analysts=10
EPS next Year (2026-12-31): EPS=3.29 | Chg30d=-0.239 | Revisions Net=-6 | Growth EPS=+2.9% | Growth Revenue=+5.3%
Additional Sources for CAMT Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle